Literature DB >> 29027626

Emerging roles for LPP in metastatic cancer progression.

Elaine Ngan1,2, Alex Kiepas3, Claire M Brown3, Peter M Siegel4,5.   

Abstract

LIM domain containing proteins are important regulators of diverse cellular processes, and play pivotal roles in regulating the actin cytoskeleton. Lipoma Preferred Partner (LPP) is a member of the zyxin family of LIM proteins that has long been characterized as a promoter of mesenchymal/fibroblast cell migration. More recently, LPP has emerged as a critical inducer of tumor cell migration, invasion and metastasis. LPP is thought to contribute to these malignant phenotypes by virtue of its ability to shuttle into the nucleus, localize to adhesions and, most recently, to promote invadopodia formation. In this review, we will examine the mechanisms through which LPP regulates the functions of adhesions and invadopodia, and discuss potential roles of LPP in mediating cellular responses to mechanical cues within these mechanosensory structures.

Entities:  

Keywords:  Focal adhesions; Invadopodia; Invasion; LPP; Metastasis; Migration

Year:  2017        PMID: 29027626      PMCID: PMC5842179          DOI: 10.1007/s12079-017-0415-5

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  171 in total

Review 1.  The LIM domain: from the cytoskeleton to the nucleus.

Authors:  Julie L Kadrmas; Mary C Beckerle
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

Review 2.  Tissue cells feel and respond to the stiffness of their substrate.

Authors:  Dennis E Discher; Paul Janmey; Yu-Li Wang
Journal:  Science       Date:  2005-11-18       Impact factor: 47.728

3.  TRIP6 and LPP, but not Zyxin, are present at a subset of telomeres in human cells.

Authors:  Samantha A Sheppard; Tatiana Savinova; Diego Loayza
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

Review 4.  Mechanosensitivity and compositional dynamics of cell-matrix adhesions.

Authors:  Herbert B Schiller; Reinhard Fässler
Journal:  EMBO Rep       Date:  2013-05-17       Impact factor: 8.807

5.  The human TRIP6 gene encodes a LIM domain protein and maps to chromosome 7q22, a region associated with tumorigenesis.

Authors:  J Yi; M C Beckerle
Journal:  Genomics       Date:  1998-04-15       Impact factor: 5.736

6.  Biotin ligase tagging identifies proteins proximal to E-cadherin, including lipoma preferred partner, a regulator of epithelial cell-cell and cell-substrate adhesion.

Authors:  Christina M Van Itallie; Amber Jean Tietgens; Angel Aponte; Karin Fredriksson; Alan S Fanning; Marjan Gucek; James M Anderson
Journal:  J Cell Sci       Date:  2013-12-11       Impact factor: 5.285

7.  SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia.

Authors:  Helen B Pearson; Pedro A Perez-Mancera; Lukas E Dow; Andrew Ryan; Pierre Tennstedt; Debora Bogani; Imogen Elsum; Andy Greenfield; David A Tuveson; Ronald Simon; Patrick O Humbert
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

Review 8.  Palladin regulation of the actin structures needed for cancer invasion.

Authors:  Paul Najm; Mirvat El-Sibai
Journal:  Cell Adh Migr       Date:  2013-01-01       Impact factor: 3.405

Review 9.  Regulation of invadopodia by mechanical signaling.

Authors:  Aron Parekh; Alissa M Weaver
Journal:  Exp Cell Res       Date:  2015-11-04       Impact factor: 3.905

10.  The cooperation between hMena overexpression and HER2 signalling in breast cancer.

Authors:  Francesca Di Modugno; Marcella Mottolese; Lucia DeMonte; Paola Trono; Michele Balsamo; Andrea Conidi; Elisa Melucci; Irene Terrenato; Francesca Belleudi; Maria Rosaria Torrisi; Massimo Alessio; Angela Santoni; Paola Nisticò
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

View more
  7 in total

1.  Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (HMGA2) and Nuclear Receptor Co-repressor 2 (NCOR2) in Osteoclastic Giant Cell-rich Tumors of Bone.

Authors:  Ioannis Panagopoulos; Kristin Andersen; Ludmila Gorunova; Marius Lund-Iversen; Ingvild Lobmaier; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

2.  DEAD-Box Helicase 27 Triggers Epithelial to Mesenchymal Transition by Regulating Alternative Splicing of Lipoma-Preferred Partner in Gastric Cancer Metastasis.

Authors:  Yirong Jin; Suzhen Yang; Xiaoliang Gao; Di Chen; Tingting Luo; Song Su; Yanting Shi; Gang Yang; Lei Dong; Jie Liang
Journal:  Front Genet       Date:  2022-05-04       Impact factor: 4.772

3.  The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation.

Authors:  Alex Kiepas; Elena Voorand; Julien Senecal; Ryuhjin Ahn; Matthew G Annis; Kévin Jacquet; George Tali; Nicolas Bisson; Josie Ursini-Siegel; Peter M Siegel; Claire M Brown
Journal:  J Biol Chem       Date:  2020-04-16       Impact factor: 5.157

4.  RITA modulates cell migration and invasion by affecting focal adhesion dynamics.

Authors:  Samira Catharina Hoock; Andreas Ritter; Kerstin Steinhäuser; Susanne Roth; Christian Behrends; Franz Oswald; Christine Solbach; Frank Louwen; Nina-Naomi Kreis; Juping Yuan
Journal:  Mol Oncol       Date:  2019-08-06       Impact factor: 6.603

5.  Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing.

Authors:  Aayushi Srivastava; Sara Giangiobbe; Abhishek Kumar; Nagarajan Paramasivam; Dagmara Dymerska; Wolfgang Behnisch; Mathias Witzens-Harig; Jan Lubinski; Kari Hemminki; Asta Försti; Obul Reddy Bandapalli
Journal:  Front Bioeng Biotechnol       Date:  2020-03-06

6.  Expression of lipoma preferred partner in mammary and extramammary Paget disease.

Authors:  Ye Liu; Yangbin Wang; Ruiqun Qi; Xiaoyun Mao; Feng Jin
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

7.  Identifying Critical States of Complex Diseases by Single-Sample Jensen-Shannon Divergence.

Authors:  Jinling Yan; Peiluan Li; Rong Gao; Ying Li; Luonan Chen
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.